CopyFind
Telmirose H 40 Tablet
medicine 📍 IN

Telmirose H 40 Tablet

65,00 ₹

Аналоги Telmirose H 40 Tablet

Найдите более доступные аналоги и дженерики для Telmirose H 40 Tablet.

Ингредиенты

Активный ингредиент: Telmisartan; Hydrochlorothiazide


Описание товара

About Telmirose H 40 Tablet

Telmirose H 40 Tablet is a medication containing the active ingredient Telmisartan, classified as Blood pressure medication. Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure and heart failure. It is a reasonable initial treatment for high blood pressure.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower.
  • Used for: Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Telmisartan, the active ingredient in Telmirose H 40 Tablet, belongs to the Blood pressure medication class. 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Telmirose H 40 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Telmirose H 40 Tablet for extended periods without medical advice.

Найти в аптеках

Сравните местные цены и расстояние для Telmirose H 40 Tablet.

Оценки посетителей

Помогите другим — оцените полезность этой страницы.

Оценок пока нет — будьте первым.